Literature DB >> 35485775

Real-World Evidence - Where Are We Now?

John Concato1, Jacqueline Corrigan-Curay1.   

Abstract

Entities:  

Year:  2022        PMID: 35485775     DOI: 10.1056/NEJMp2200089

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  Cardiovascular adverse events in oncology trials: understanding and appreciating the differences between clinical trial data and real-world reports.

Authors:  Michael S Ewer; Jay Herson
Journal:  Cardiooncology       Date:  2022-07-19

Review 2.  Real-World Evidence-Current Developments and Perspectives.

Authors:  Friedemann Schad; Anja Thronicke
Journal:  Int J Environ Res Public Health       Date:  2022-08-16       Impact factor: 4.614

3.  Licensing of Orphan Medicinal Products-Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021.

Authors:  Frauke Naumann-Winter; Franziska Wolter; Ulrike Hermes; Eva Malikova; Nils Lilienthal; Tania Meier; Maria Elisabeth Kalland; Armando Magrelli
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

Review 4.  Convalescent plasma and COVID-19: Time for a second-second look?

Authors:  Michael J Joyner; Rickey E Carter; DeLisa Fairweather; R Scott Wright
Journal:  Transfus Med       Date:  2022-09-11       Impact factor: 2.057

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.